ARIANA CAMPOS YANG
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/60 - Laboratório de Imunologia Clínica e Alergia, Hospital das Clínicas, Faculdade de Medicina
LIM/60 - Laboratório de Imunologia Clínica e Alergia, Hospital das Clínicas, Faculdade de Medicina
6 resultados
Resultados de Busca
Agora exibindo 1 - 6 de 6
bookPart Anafilaxia(2016) LIMA, Cynthia Mafra Fonseca de; YANG, Ariana Campos; GALVãO, Clóvis Eduardo Santos; CASTRO, Fábio Fernandes MoratobookPart Dermatite Atópica(2016) YANG, Ariana Campos; CASTRO, Fábio Fernandes MoratobookPart Alergia Alimentar(2016) YANG, Ariana Campos; POMIECISNKI, Fabiane; CASTRO, Fábio Fernandes MoratoconferenceObject Cross-Reactivity Among Cereal Grains(2016) MENDONCA, Juliana Guimaraes; CASTRO, Roberta Almeida; CORDOVA, Pablo Torres; MEIRELES, Paula Rezende; FIGO, Daniele Danella; SANTOS, Keity Souza; KALIL, Jorge; CASTRO, Fabio Fernandes Morato; YANG, Ariana C.- Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow's milk allergy in Brazil(2016) GUEST, Julian F.; YANG, Ariana C.; OBA, Jane; RODRIGUES, Maraci; CAETANO, Rosane; POLSTER, LilianObjective: To estimate the cost-effectiveness of three alternative dietetic strategies for cow's milk allergy in Brazil: 1) using an extensively hydrolyzed casein formula (eHCF; -Nutramigen) as a first-line formula, but switching to an amino acid formula (AAF) if infants remain symptomatic; 2) using an AAF as a first-line formula and then switching to an eHCF after 4 weeks once infants are symptom-free, but switching back to an AAF if infants become symptomatic; and 3) using an AAF as a first-line formula and keeping all infants on that formula. The analysis was conducted from the perspective of the Brazilian public health care system, Sistema Unico de Saude. Methods: Decision modeling was used to estimate the probability of immunoglobulin E (IgE)-mediated and non-IgE-mediated allergic infants developing tolerance to cow's milk by 12 months from starting a formula. The models also estimated the Sistema Unico de Saude cost (at 2013/2014 prices) of managing infants over 12 months after starting a formula, as well as the relative cost-effectiveness of each of the dietetic strategies. Results: The probability of developing tolerance to cow's milk by 12 months from starting a formula was higher among infants with either IgE-mediated or non-IgE-mediated allergy who were initially fed with an eHCF, compared with those who were initially fed with an AAF. The total health care cost of initially feeding an eHCF to cow's milk allergic infants was less than that of initially feeding both IgE-mediated and non-IgE-mediated infants with an AAF. Conclusion: Within the study's limitations, using an eHCF instead of an AAF for the first-line management of newly-diagnosed infants with cow's milk allergy affords a cost-effective use of publicly funded resources, since it improves the outcome for less cost.
bookPart Esofagite Eosinofílica(2016) BARBOSA, Adriana Marcia S. Cunha; YANG, Ariana Campos